NCT00438178View on ClinicalTrials.gov

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

October 31, 2007

Conditions
Hematological Malignancies
Interventions
DRUG

Obatoclax mesylate (GX15-070MS)

Trial Locations (3)

20007

Georgetown University Medical Center, Washington D.C.

77030

MD Anderson Cancer Center, Houston

M5G 2M9

Princess Margaret Hospital, Toronto

Sponsors

Lead Sponsor

Gemin X
All Listed Sponsors
lead

Gemin X

INDUSTRY

NCT00438178 - Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies | Biotech Hunter | Biotech Hunter